famotidine has been researched along with Allergy, Drug in 7 studies
Famotidine: A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Paclitaxel-based chemotherapy continues to be an integral component of breast cancer treatment." | 3.81 | Stopping paclitaxel premedication after two doses in patients not experiencing a previous infusion hypersensitivity reaction. ( Berger, MJ; Layman, R; Lustberg, MB; Macrae, E; Mrozek, E; Phillips, G; Ramaswamy, B; Shapiro, CL; Shaver, K; Vargo, C; Vincent, M; Wesolowski, R, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Foer, D | 1 |
| Marquis, K | 1 |
| Romero, N | 1 |
| Castells, MC | 1 |
| Berger, MJ | 1 |
| Vargo, C | 1 |
| Vincent, M | 1 |
| Shaver, K | 1 |
| Phillips, G | 1 |
| Layman, R | 1 |
| Macrae, E | 1 |
| Mrozek, E | 1 |
| Ramaswamy, B | 1 |
| Wesolowski, R | 1 |
| Shapiro, CL | 1 |
| Lustberg, MB | 1 |
| Kim, YI | 1 |
| Park, CK | 1 |
| Park, DJ | 1 |
| Wi, JO | 1 |
| Han, ER | 1 |
| Koh, YI | 1 |
| Saha, N | 1 |
| Sachdev, A | 1 |
| Bhasin, DK | 1 |
| Sankaranahyanan, A | 1 |
| Khosla, PP | 1 |
| Singh, K | 1 |
| Sharma, PL | 1 |
| Markman, M | 2 |
| Kennedy, A | 2 |
| Webster, K | 2 |
| Peterson, G | 2 |
| Kulp, B | 2 |
| Belinson, J | 2 |
| Morisset, M | 1 |
| Moneret-Vautrin, DA | 1 |
| Loppinet, V | 1 |
| Grandidier, S | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Feasibility of a Randomized Controlled Clinical Trial Comparing the Use of Cetirizine to Replace Diphenhydramine in the Prevention of Reactions Related to Paclitaxel[NCT04237090] | Phase 3 | 27 participants (Actual) | Interventional | 2020-02-14 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 trials available for famotidine and Allergy, Drug
| Article | Year |
|---|---|
Clinical evaluation of the effect of omeprazole, cimetidine, famotidine and ranitidine on histamine induced cutaneous wheal and flare response.
Topics: Adult; Cimetidine; Drug Hypersensitivity; Dyspepsia; Famotidine; Female; Histamine; Histamine H2 Ant | 1993 |
Paclitaxel-associated hypersensitivity reactions: experience of the gynecologic oncology program of the Cleveland Clinic Cancer Center.
Topics: Adult; Aged; Aged, 80 and over; Clinical Protocols; Desensitization, Immunologic; Dexamethasone; Dip | 2000 |
5 other studies available for famotidine and Allergy, Drug
| Article | Year |
|---|---|
Challenges and safety of beta-lactam desensitization during extracorporeal membrane oxygenation.
Topics: Acetates; Allergens; Anaphylaxis; Anti-Infective Agents; Antibiotic Prophylaxis; beta-Lactams; Cetir | 2019 |
Stopping paclitaxel premedication after two doses in patients not experiencing a previous infusion hypersensitivity reaction.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brea | 2015 |
A case of famotidine-induced anaphylaxis.
Topics: Adrenal Cortex Hormones; Anaphylaxis; Coma; Cross Reactions; Drug Hypersensitivity; Dyspnea; Epineph | 2010 |
An effective and more convenient drug regimen for prophylaxis against paclitaxel-associated hypersensitivity reactions.
Topics: Anti-Inflammatory Agents; Antineoplastic Agents, Phytogenic; Dexamethasone; Diphenhydramine; Drug Ad | 1999 |
Cross-allergy to ranitidine and nizatidine.
Topics: Adult; Anti-Ulcer Agents; Cross Reactions; Drug Hypersensitivity; Famotidine; Gastroesophageal Reflu | 2000 |